Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP360969.RAdrDbouCb2IkRrD8X0BL2FQ_nFc59Fim4FB44oqxbKCQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP360969.RAdrDbouCb2IkRrD8X0BL2FQ_nFc59Fim4FB44oqxbKCQ130_assertion type Assertion NP360969.RAdrDbouCb2IkRrD8X0BL2FQ_nFc59Fim4FB44oqxbKCQ130_head.
- NP360969.RAdrDbouCb2IkRrD8X0BL2FQ_nFc59Fim4FB44oqxbKCQ130_assertion description "[Thus we have identified delta-catenin (not previously associated with prostatic adenocarcinoma) and confirmed the potential of PSMA as potential candidates for the diagnosis and management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360969.RAdrDbouCb2IkRrD8X0BL2FQ_nFc59Fim4FB44oqxbKCQ130_provenance.
- NP360969.RAdrDbouCb2IkRrD8X0BL2FQ_nFc59Fim4FB44oqxbKCQ130_assertion evidence source_evidence_literature NP360969.RAdrDbouCb2IkRrD8X0BL2FQ_nFc59Fim4FB44oqxbKCQ130_provenance.
- NP360969.RAdrDbouCb2IkRrD8X0BL2FQ_nFc59Fim4FB44oqxbKCQ130_assertion SIO_000772 12115574 NP360969.RAdrDbouCb2IkRrD8X0BL2FQ_nFc59Fim4FB44oqxbKCQ130_provenance.
- NP360969.RAdrDbouCb2IkRrD8X0BL2FQ_nFc59Fim4FB44oqxbKCQ130_assertion wasDerivedFrom befree-2016 NP360969.RAdrDbouCb2IkRrD8X0BL2FQ_nFc59Fim4FB44oqxbKCQ130_provenance.
- NP360969.RAdrDbouCb2IkRrD8X0BL2FQ_nFc59Fim4FB44oqxbKCQ130_assertion wasGeneratedBy ECO_0000203 NP360969.RAdrDbouCb2IkRrD8X0BL2FQ_nFc59Fim4FB44oqxbKCQ130_provenance.